• At Home With Art

  Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art

  Krishna Gopalan - August 19, 2017

• Managing Growth 2017- Part 2

  Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal

  March 17, 2017

• Managing Growth 2017- Part 1

  CEOs from diverse sectors on what's in store for 2017

  March 17, 2017

• Will Sun rise again?

  Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?

  Kripa Mahalingam - June 15, 2015

• Critical condition

  Drug majors are shifting clinical trials out of India as lawmakers turn on the heat

  Kripa Mahalingam - June 17, 2015